Please enable JavaScript.
Coggle requires JavaScript to display documents.
CANCER, Navigating the brain of healthcare payers, Premise: Cancer the…
CANCER
Old age and death
Palliative care is required only at the end of life
Chemotherapy is not linked to palliative care
Multigenic platforms are useless beyond initial diagnosis (and what is that?)
Liquid biopsy (also what is that?)
Birth
Cancer is born only with a screening test
Blind spots
Non-evaluable diseases (cancer without screening tests)
Screen-able but forgotten diseases (yes, ¡lung!)
Non traditional risk factors
Non traditional screening tests (liquid biopsy, exhaled biopsy etc)
Early means screenable
are there studies on neoadjuvant and adjuvant settings?
Are there mutations and biomarkers at this stage?
Mature life
Lineal trajectory
Cancer patients are diagnosed and treated with chemoterapy
main cost is in chemo and radiotherapy
Oral directed therapies are not antineoplastic drugs
Most patients are advanced cases and will die being expensive
Cost analysis are the input for the benefit decision
Every MD prescribes what he wants
Pharma and MDs are a kind of coalition
What matters is the report to CAC (Colombia)
Is there a world beyond overall survival?
Navigating the brain of healthcare payers
Premise: Cancer the emperator of costs